BioSpace News Archive

GN Store Nord: Transactions in Relation to Share Buyback Program – Jan. 23, 2018

The share buyback program has been initiated in order to reduce the company’s share capital and to cover obligations under the long-term incentive program.

January 23, 2018
·
2 min read
Business

Philips Provides Royal Victoria Regional Health Centre with New Innovative Technology for Cardiac Solutions

The facility ensures that advanced cardiac care is now available in North Simcoe Muskoka, giving patients the same fast access to heart services as those in the rest of Ontario.

January 23, 2018
·
3 min read
Business

BioLife Solutions Announces SAVSU Alliance With World Courier

The combination of World Courier’s global logistics network and SAVSU’s patent pending.

January 23, 2018
·
5 min read
BioCanCell Announces Terms of $25M Funding Round

The investment will be priced at NIS 1.60 per share ($0.46 at current exchange rates), reflecting a Company valuation of approximately $51 million on a fully-diluted basis.

January 23, 2018
·
3 min read
Genetown

Skyhawk Therapeutics Launches With $8M in Seed Financing to Advance Its Novel Platform and Portfolio of Small Molecules That Correct RNA Expression

Skyhawk today announced the close of $8M in seed funding led by major family and biotech investors, including Tim Disney, the Duke of Bedford, Alexandria Venture Investments, and other undisclosed private investors.

January 23, 2018
·
7 min read
Noxxon Issues Fourth Tranche of Odirnane Bonds

NOXXON maintains an updated summary table of ODIRNANE tranches issued as well as the status of issued bonds and warrants in the investors’ section of its website www.noxxon.com.

January 23, 2018
·
2 min read
Pharm Country

Helius Medical Technologies Completes Reverse Split of its Class A Common Stock

Helius Class A common stock will begin trading on a post-split basis at market open on January 23, 2018.

January 23, 2018
·
6 min read
Business

LifeArc and Milner Therapeutics Institute Announce a New Partnership in Artificial Intelligence and Machine Learning for Target Discovery

LifeArc and the Milner Therapeutics Institute at the University of Cambridge, today announced a new partnership to identify and validate new drug targets in immuno-oncology and respiratory diseases.

January 23, 2018
·
1 min read
Business

Genmab Announces 2017 Net Sales Figures for DARZALEX (Daratumumab)

Net sales of DARZALEX in 2017 totaled USD 1,242 million.

January 23, 2018
·
6 min read
Consortium Including Trakcel Awarded GBP 1.4 Million From Innovate UK for Commercialisation of Rexgenero Cell Therapy

The project will focus on and design a cost effective commercial manufacturing strategy for Rexgenero’s novel autologous cell therapy REX-001.

January 23, 2018
·
2 min read